| Efficacy and safety of midostaurin in advanced systemic mastocytosis J Gotlib, HC Kluin-Nelemans, TI George, C Akin, K Sotlar, O Hermine, ... New England Journal of Medicine 374 (26), 2530-2541, 2016 | 488 | 2016 |
| Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma … K Hartmann, L Escribano, C Grattan, K Brockow, MC Carter, ... Journal of Allergy and Clinical Immunology 137 (1), 35-45, 2016 | 419 | 2016 |
| Altered translation of GATA1 in Diamond-Blackfan anemia LS Ludwig, HT Gazda, JC Eng, SW Eichhorn, P Thiru, R Ghazvinian, ... Nature medicine 20 (7), 748-753, 2014 | 312 | 2014 |
| Advances in the classification and treatment of mastocytosis: current status and outlook toward the future P Valent, C Akin, K Hartmann, G Nilsson, A Reiter, O Hermine, K Sotlar, ... Cancer research 77 (6), 1261-1270, 2017 | 272 | 2017 |
| Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation J Gotlib, C Berubé, JD Growney, CC Chen, TI George, C Williams, ... Blood 106 (8), 2865-2870, 2005 | 260 | 2005 |
| The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment J Gotlib, JE Maxson, TI George, JW Tyner Blood, The Journal of the American Society of Hematology 122 (10), 1707-1711, 2013 | 202 | 2013 |
| Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation AB Pillai, TI George, S Dutt, P Teo, S Strober The journal of immunology 178 (10), 6242-6251, 2007 | 188 | 2007 |
| Host natural killer T cells induce an interleukin-4–dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host … AB Pillai, TI George, S Dutt, S Strober Blood, The Journal of the American Society of Hematology 113 (18), 4458-4467, 2009 | 187 | 2009 |
| Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens DA Arber, TI George The American journal of surgical pathology 29 (12), 1549-1557, 2005 | 181 | 2005 |
| Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal P Valent, C Akin, K Hartmann, I Alvarez-Twose, K Brockow, O Hermine, ... Hemasphere 5 (11), e646, 2021 | 165 | 2021 |
| International working group-myeloproliferative neoplasms research and treatment (IWG-MRT) & European competence network on mastocytosis (ECNM) consensus response criteria in … J Gotlib, A Pardanani, C Akin, A Reiter, T George, O Hermine, ... Blood, The Journal of the American Society of Hematology 121 (13), 2393-2401, 2013 | 159 | 2013 |
| Primary radiotherapy for localized orbital MALT lymphoma QT Le, SM Eulau, TI George, R Hildebrand, RA Warnke, SS Donaldson, ... International Journal of Radiation Oncology* Biology* Physics 52 (3), 657-663, 2002 | 155 | 2002 |
| Contrast‐enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma L Esserman, N Hylton, T George, N Weidner The breast journal 5 (1), 13-21, 1999 | 146 | 1999 |
| Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal P Valent, K Sotlar, WR Sperr, L Escribano, S Yavuz, A Reiter, TI George, ... Annals of oncology 25 (9), 1691-1700, 2014 | 139 | 2014 |
| Naive and memory T cells induce different types of graft-versus-host disease S Dutt, D Tseng, J Ermann, TI George, YP Liu, CR Davis, CG Fathman, ... The Journal of Immunology 179 (10), 6547-6554, 2007 | 136 | 2007 |
| Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts P Valent, C Akin, K Hartmann, G Nilsson, A Reiter, O Hermine, K Sotlar, ... Theranostics 10 (23), 10743, 2020 | 132 | 2020 |
| Cytogenetically aberrant cells in the stem cell compartment (CD34+ lin-) in acute myeloid leukemia B Mehrotra, TI George, K Kavanau, H Avet-Loiseau, D Moore, CL Willman, ... | 124 | 1995 |
| Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial DJ DeAngelo, TI George, A Linder, C Langford, C Perkins, J Ma, ... Leukemia 32 (2), 470-478, 2018 | 120 | 2018 |
| New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis A Reiter, TI George, J Gotlib Blood, The Journal of the American Society of Hematology 135 (16), 1365-1376, 2020 | 113 | 2020 |
| Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified SA Wang, W Tam, AG Tsai, DA Arber, RP Hasserjian, JT Geyer, TI George, ... Modern Pathology 29 (8), 854-864, 2016 | 111 | 2016 |
Mr Olivier HermineProfessor of hematology,Verified email at aphp.fr
